[1]
“Nanocarrier-based formulations: Regulatory Challenges, Ethical and Safety Considerations in Pharmaceuticals”,
AJP
, vol. 18, no. 02, Jun. 2024, doi:
10.22377/ajp.v18i02.5444
.